MUC5AC is a secretory mucin aberrantly expressed in various cancers. In lung cancer, MUC5AC is overexpressed in both primary and metastatic lesions; however, its functional role is not well understood. The present study was aimed at evaluating mechanistic role of MUC5AC on metastasis of lung cancer cells. Clinically, the overexpression of MUC5AC was observed in lung cancer patient tissues and was associated with poor survival. In addition, the overexpression of Muc5ac was also observed in genetically engineered mouse lung adenocarcinoma tissues (Kras G12D ; Trp53 R172H/+ ; AdCre) in comparison with normal lung tissues. Our functional studies showed that MUC5AC knockdown resulted in significantly decreased migration in two lung cancer cell lines (A549 and H1437) as compared with scramble cells. Expression of integrins (α5, β1, β3, β4 and β5) was decreased in MUC5AC knockdown cells. As both integrins and MUC5AC have a von Willebrand factor domain, we assessed for possible interaction of MUC5AC and integrins in lung cancer cells. MUC5AC strongly interacted only with integrin β4. The co-localization of MUC5AC and integrin β4 was observed both in A549 lung cancer cells as well as genetically engineered mouse adenocarcinoma tissues. Activated integrins recruit focal adhesion kinase (FAK) that mediates metastatic downstream signaling pathways. Phosphorylation of FAK (Y397) was decreased in MUC5AC knockdown cells. MUC5AC/integrin β4/FAK-mediated lung cancer cell migration was confirmed through experiments utilizing a phosphorylation (Y397)-specific FAK inhibitor. In conclusion, overexpression of MUC5AC is a poor prognostic marker in lung cancer. MUC5AC interacts with integrin β4 that mediates phosphorylation of FAK at Y397 leading to lung cancer cell migration.
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INRODUCTION
Mucins contribute viscous properties to the lung and help trapinhaled microbes and particulates. Aberrant expression and accumulation of mucins has been associated with lung cancer, 1 inflammatory conditions 2 and other chronic diseases. [3] [4] [5] Mucins interact with various molecules and affect cell-cell interaction during cancer progression and metastasis. [6] [7] [8] MUC5AC is a high molecular weight secretory polymeric mucin, synthesized as a glycoprotein in a selective and cell-specific manner. 5, 9 Multiple cysteine-rich domains in both N-and C-terminal regions of MUC5AC are responsible for its disulfide-mediated polymerization, which is critical for gel-forming properties. 10 MUC5AC is expressed in the trachea and bronchi, but not in the bronchioles and smaller alveolar epithelial cells. 11 It is also observed in the goblet cells of the surface epithelium and in the glandular ducts. 11 MUC5AC expression has been shown to increase significantly during the progression from atypical adenomatous hyperplasia (AAH) in the lung to adenocarcinoma. 12 Alterations in the MUC5AC expression have been associated with dedifferentiation of bronchial epithelium. 13 Yu et al. 14 reported an increased expression of MUC5AC in smoking-associated lung cancers compared with non-smokers lung cancers patients.
Epidermal growth factor family and mitogen-activated protein kinase cascades regulate MUC5AC expression. 11 Treatment of H292 lung cancer cells with growth factors such as epidermal growth factor and TNF-α resulted in increased expression of MUC5AC. 11 Epidermal growth factor-mediated EGFR activation upregulates MUC5AC there by activating Ras/Raf pathway, which in turn leads to cancer cell proliferation. Overproduction of MUC5AC is associated with lung cancer progression and appears to be a marker of poor prognosis. 15 Although overexpression of many mucins seems to have a significant role in chemoresistance, the effect of MUC5AC expression has not been studied. [16] [17] [18] Similarly, the precise biological role and mechanism of action of MUC5AC in lung carcinogenesis is poorly understood.
Integrins belong to the family of cell adhesion receptors and have been implicated in cancer cell migration and invasion. 19 Integrin signaling is strongly associated with extracellular matrix proteins during metastasis. 20 In addition, integrins appear to be specifically associated with growth factors and oncogenes for tumor progression. 19, 21, 22 MUC5AC induces migration of pancreatic cancer cells by enhancing the integrins expression. 23 However, functional significance and co-existence of MUC5AC and integrins in lung cancer is not well elucidated. In the present study, we have evaluated the preclinical and clinical importance of MUC5AC in lung cancer and attempted to identify the molecular mechanism of MUC5AC-mediated lung cancer cell migration through integrin β4/focal adhesion kinase (FAK) signaling. 1 
RESULTS

Stable knockdown of MUC5AC in lung cancer cells and its effect on cell growth
To explore the functional significance of MUC5AC in lung cancer, we performed stable knockdown of MUC5AC in two lung adenocarcinoma cell lines, A549 and H1437, which endogenously express high levels of MUC5AC. MUC5AC knockdown was validated using western blot and quantitative real-time PCR analysis. Both MUC5AC protein (Figures 1a and d) and mRNA (Figures 1b and e) expression were significantly reduced (A549 (P = 0.007) and H1437 (P = 0.001)) in MUC5AC knockdown cells as compared with respective scramble cells. MUC5AC knockdown was also confirmed by confocal studies (Figures 1c and f) . MUC5AC knockdown cells had a significantly decreased growth rate (P = 0.01) compared with scramble cells (Supplementary Figure  1A) . This appears to be due to decreased phosphorylation of Akt (Ser473) and extracellular signal-regulated kinase 1/2 (ERK1/2) at T202/Y204 (Supplementary Figure 1B) . These results suggest that overexpression of MUC5AC has an oncogenic role in lung cancer.
MUC5AC expression in human lung cancer tissues and its prognostic utility We analyzed the MUC5AC expression in lung cancer patient tissues. Clinical information was available on 21 patients with a median age at diagnosis of 63 years (range: 44-79 years). Survival information was available on 20 patients. Patients without MUC5AC expression in their tumor cells had a longer survival compared with MUC5AC expressing tumors (P = 0.029). Five-year overall survival for MUC5AC-negative patients was 93% (95% confidence interval, 59-99%) compared with 67% in the MUC5AC expressing patients (95% confidence interval, 19-90%) (Figure 2a ), indicating that MUC5AC is a prognostic marker for worse outcomes in lung cancer. (Figure 2b ). The control mice lung tissues (n = 4) showed basal level of Muc5ac. Transcript level analysis of Muc5ac in mouse lung adenocarcinoma tissues shows that Muc5ac is significantly increased in mouse lung adenocarcinoma tissues (P = 0.01) compared with normal lung tissues (Figure 2c ).
MUC5AC-induced lung cancer cell migration As MUC5AC is associated with metastasis, 14, 24 we examined the role of MUC5AC on migration of lung cancer cells. Migration of MUC5AC knockdown cells was significantly reduced in comparison with scramble cells (A549 (P = 0.03) and H1437 (P = 0.02)) (Figures 3a and c) . Further, the expression of mesenchymal markers N-cadherin and vimentin was decreased in MUC5AC knockdown cells (Figures 3b and d) , and in contrast, epithelial markers CK-18 and E-cadherin were upregulated (Figures 3b and d) as compared with scramble cells. The endogenous level of E-cadherin protein expression is below the basal level or undetected in A549 cells, 25 hence we analyzed another epithelial marker CK-18.
MUC5AC interacts with integrin β4 in lung cancer cells Upon MUC5AC knockdown, expression of integrins such as integrin α5, β1, β3, β4 and β5 was decreased (Figure 4a ). Integrins mediate inter-and intracellular signaling by heterodimerization. 19 Integrins promote tumor cell migration and invasion by binding with extracellular matrix, which provides a suitable environment for tumor cell motility and invasion. 26, 27 These results suggest that integrins may also have an important role in lung cancer cell migration.
Integrins also associate with growth factors and oncogenes during cancer cell migration and invasion. 21, 22, 28, 29 Both integrins and MUC5AC share the von Willebrand factor domain, 30, 31 which is required for dimerization or oligomerization. We hypothesized that the presence of von Willebrand factor domains in both integrins and MUC5AC may lead to their interaction with each other. To assess interaction between these two proteins, we pulled down MUC5AC and probed with various integrins (α5, β1, β3, β4 and β5). MUC5AC specifically interacted with integrin β4 as indicated by immunoprecipitation assay (Figure 4b ), whereas there was no interaction observed with other integrins (Figure 4c ). In addition, we also pulled down integrin β4 and probed with MUC5AC, and observed that MUC5AC and integrin β4 interact each other in lung cancer cells (Figure 4d ). Similarly, we have also confirmed the co-localization of MUC5AC and integrin β4 in A549 cells by confocal analysis (Figure 4e ). Thus, MUC5AC associates with integrin β4 in lung cancer cells.
Co-localization of Muc5ac and integrin β4 in genetically engineered mouse adenocarcinoma tissues To validate the MUC5AC/integrin β4 association in mouse lung adenocarcinoma tissues, we examined the association of Muc5ac and integrin β4 in the mouse lung adenocarcinoma (Kras G12D ; Trp53 R172H/+ ;AdCre). Muc5ac was strongly co-localized with integrin β4 in various mouse adenocarcinoma tissues, which indicates that Muc5ac/integrin β4 association may be required for lung cancer initiation, progression and metastasis ( Figure 5 ).
Molecular mechanisms of MUC5AC-mediated lung cancer cell migration FAK is a key downstream signaling molecule triggered by integrin activation. [32] [33] [34] Activation of integrins leads to recruitment of FAK, Figure 2 . Expression of MUC5AC in lung carcinoma tissues. To investigate the clinical significance of MUC5AC in lung cancer, its expression was analyzed in patient samples (#20). The results show that overexpression of MUC5AC (Composite score (CS)40) is associated with poor prognosis of lung cancer patients (a). Muc5ac expression in mouse lung adenocarcinoma tissues. Muc5ac is overexpressed in spontaneous Kras G12D ;Trp53 R172H/+ ;AdCre mouse lung adenocarcinoma tissues. Muc5ac is overexpressed in mouse lung adenocarcinoma tissues than normal lung tissues (b). In addition, quantitative real-time PCR analysis shows that Muc5ac transcript is significantly higher (P = 0.01) in lung adenocarcinoma as compared with normal lung tissues (c). **Po 0.01.
which is responsible for migration and metastasis of cancer cells. 27, 35 Upon MUC5AC knockdown, phosphorylation of FAK (Y397) was decreased ( Figure 6a and supplementary Figure 2 ), suggesting that MUC5AC induces lung cancer cell migration, may be in part, through integrin β4-FAK pathway.
Inhibition of FAK phosphorylation attenuates lung cancer cell migration As demonstrated above, MUC5AC promotes cell migration through the FAK pathway. To evaluate the role of phosphorylation of FAK in this process, a phosphorylation-specific inhibitor for FAK (FAK inhibitor 14, phosphorylation-specific inhibitor) was used. 36 Following exposure to the FAK inhibitor (20 μM), phosphorylation of FAK (Y397) was decreased in A549 cells (Figure 6b ). On treatment with FAK inhibitor, we observed the downregulation of N-cadherin (Figure 6b ). We also observed that migration of lung cancer cells was significantly reduced in FAK inhibitor-treated cells as compared with their corresponding untreated controls (Figure 7a) . Similarly, wound-healing capacity was significantly reduced following treatment with a FAK inhibitor as compared with untreated cells (Figure 7b ). These results confirm the importance of FAK phosphorylation in mediating MUC5AC-induced cell migration.
MUC5AC confers cisplatin resistance in lung cancer cells Overexpression of mucins in cancer cells confers chemoresistance that leads to cancer cell survival and tumor relapse. 16, [37] [38] [39] We performed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay with MUC5AC knockdown and scramble cells after exposure to various concentrations of cisplatin. MUC5AC knockdown cells were more sensitive to cisplatin as compared with scramble cells, which suggests that endogenous expression of MUC5AC confers cisplatin resistance (Supplementary Figure 3A) . Further, cisplatin treated MUC5AC knockdown cells have less viability than cisplatin treated scramble cells (Supplementary Figure 3B) .
DISCUSSION
Overexpression of mucins is associated with proliferation and metastasis of lung cancer cells. [40] [41] [42] MUC5AC is a secretory glycoprotein, which is normally expressed in the lung; but its expression is altered in lung cancer. 4, 5, [43] [44] [45] In the present study, we elucidate the role of MUC5AC in lung cancer cell growth and metastasis. Following MUC5AC knockdown in two lung adenocarcinoma cell lines, we observed significant reduction of growth. In addition, decreased phosphorylation of AKT (Ser473) and ERK (Thr202/Tyr204) was observed in MUC5AC knockdown cells as compared with scramble cells, suggesting that MUC5AC has an oncogenic role in lung cancer. Further, we analyzed the clinical significance of MUC5AC in lung cancer, and observed that overexpression of MUC5AC was associated with poor outcomes. Similarly, Muc5ac is overexpressed in mice lung adenocarcinoma tissues (Kras G12D ;Trp53 R172H/+ ;AdCre), suggesting that Muc5ac may have a significant role in lung pathogenesis.
MUC5AC is found to be overexpressed in both primary and metastatic lesions in multiple cancers. 14, 46, 47 In this study, we observed that MUC5AC knockdown leads to significantly less migratory capacity. Mesenchymal cell markers N-cadherin and vimentin were decreased in MUC5AC knockdown cells, in contrast, epithelial marker CK-18 and E-cadherin were increased. These result suggests that MUC5AC is involved in the migration of lung cancer cells.
Interestingly, silencing of MUC5AC resulted in decreased expression of integrins α5, β1, β3, β4 and β5, suggesting that MUC5AC/integrin signaling may be involved in the migration of lung cancer cells. Previous studies have well demonstrated that integrins induces the metastatic signaling through heterodimerization process through α-and β-subunit. 26, 48 In addition, integrins also activate metastatic signaling by binding with various oncogenes and growth factors. 21, 22, 28 Both integrins and MUC5AC have a von Willebrand factor domain, which is responsible for dimerization or oligomerization. 30, 31 This raises the possibility that von Willebrand factor domain of the two molecules may interact with each other in lung cancer cells. We performed reciprocal immunoprecipitation assay and observed an interaction between MUC5AC and integrin β4. Other integrins did not show any interactions with MUC5AC in lung cancer cells. Further co-localization of MUC5AC and integrin β4 was observed both in lung cancer cell lines and mice lung adenocarcinoma tissues. These results strongly indicate that MUC5AC/integrin β4 interaction may be required for lung cancer pathogenesis. To support our findings, previous studies have demonstrated that integrin β4 is overexpressed in non-small cell lung cancer and associated with lung cancer pathogenesis. 22, 49 Our next goal was to analyze the MUC5AC/integrin-dependent metastatic downstream signaling alteration in lung cancer cells. Previous studies indicated that integrins activate FAK downstream Figure 4 . Interaction of MUC5AC and integrin β4 in lung cancer cells. Upon knocking down of MUC5AC, the expression of integrin α5, β1, β3, β4 and β5 were decreased as compared with scramble cells (a). Co-immunoprecipitation assay results show that MUC5AC strongly interacts with integrin β4 (b), but not with other integrins (α5, β1, β3 and β5) (c). Similarly, we have also performed reciprocal co-immunoprecipitation assay to pull down integrin β4 and probed with MUC5AC (d). MUC5AC strongly interacts with integrin β4 in lung cancer cells. Co-localization of MUC5AC and integrin β4 was also observed in A549 cells as indicated by confocal analysis (e). R172H/+ ), we analyzed the co-existence of MUC5AC and integrin β4 by immunofluorescence studies. Muc5ac (green) is strongly co-localized with integrin β4 (red) in mouse lung adenocarcinoma tissues. signaling during migration of cancer cells. 35, 50 We observed that phosphorylation of FAK at Y397 was reduced in MUC5AC knockdown cells, which suggests that MUC5AC regulates integrin-FAK-mediated lung cancer cell migration. Previous studies suggest that FAK-mediated signal transduction for cancer cell migration may be triggered by integrins. 35, 50 In the present study, inhibition of phosphorylation of FAK resulted in decreased migration in both MUC5AC knockdown and scramble cells. In addition, MUC5AC knockdown cells had lesser migratory capacity in comparison with scramble treated with phospho FAK inhibitor, which suggests that overexpression of MUC5AC may induce integrin β4 mediated lung cancer cell migration through FAK activation (Figure 8) .
Overexpression of mucins has been associated with chemoresistance. 16, 37, 38 However, the effects of MUC5AC on chemosensitivity have not been explored so far. A previous study demonstrated that expression of MUC5AC was associated with resistance to methotrexate, but sensitivity to 5-FU. 39 Platinum agents including cisplatin are routinely used in the treatment of lung cancer. 51 We found that MUC5AC knockdown cells were more sensitive to the cytotoxic effects of cisplatin, which suggests that MUC5AC is involved in chemoresistance of lung cancer cells. (Figure 8 ).
MATERIALS AND METHODS
Patient characteristics
Clinical information was collected on patients with non-small cell lung cancer. The human lung tissue microarrays were obtained through the Chicago Tissue Procurement Shared Resource facility for this study. All the tissues were obtained after getting consent from all the tissue donors prior to their death, as per the University of Chicago Institutional Review Boardapproved protocol.
Scoring and statistical analysis
Immunohistochemistry was performed on the samples collected from these patients using anti-MUC5AC (mouse, 1:400, Abcam Cat #3649, Cambridge, MA, USA) mouse monoclonal antibody. Each sample was given a composite score based on intensity and extent of tissue staining.
Intensity was graded on a four point scale: − (0), + (1), ++ (2) and +++ (3). Extent of staining was graded as: 1 (0-24%), 2 (25-49%), 3 (50-74%) and 4 (75-100%). The composite score was obtained by multiplying the two values. A generalized linear mixed model was used to test for difference in maximum composite score. Pairwise comparisons on the same patient were adjusted for multiple comparisons with Tukey's method. Kaplan-Meier method was used to estimate overall survival distributions, and the log rank test was used to compare survival distributions.
Generation of spontaneous lung cancer mouse model
Genetically engineered mouse models for lung cancer (KP) were developed by the Tuveson laboratory 52 by crossing LSL-Kras G12D (B6.129-Krastm4Tyj (01XJ6)) mice with Trp53 R172H to generate Kras G12D ; Trp53 R172H/+ (KP) as described previously. 53, 54 The F1 progeny were genotyped for Kras G12D and Trp53 R172H/+ genes using specific primers for Kras and Trp53 genes by PCR. Animals that were positive for both Kras G12D and Trp53 R172H/+ were randomized into two groups, one group infected with AdCre-luciferase retroviral vector intra nasally (University of Iowa, Gene and vector core, IA, USA) and other with vehicle control. Four weeks post infection, the animals were injected with luciferin intra-peritoneally to monitor the tumor growth (non-invasive in vivo live imaging using IVIS system). Mice were fed with food and water ad libitum and subjected to 12 h light/dark cycle. The mice studies were performed in accordance with the US Public Health Service 'Guidelines for the Care and Use of Laboratory Animals' under an approved protocol by the Institutional Animal Care and Use Committee of the University of Nebraska Medical Center.
Cell culture and transfection A549 and H1437 non-small cell lung cancer cell lines were used in these experiments. A549 is a human alveolar adenocarcinoma cell line derived from the primary lung cancer tissue of a Caucasian male, whereas H1437 is an adenocarcinoma cell line derived from pleural effusions of lung cancer cells metastasized to pleural space of a Caucasian male patient. A549 and H1437 possess similarity in morphology, epithelial type. The most common mutations observed in H1437 are CDKN2A and TP53, whereas A549 harbors a KRAS mutation.
These cells were cultured in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum and antibiotics. 25 The cells were incubated in a humidified atmosphere at 37 o C with 5% CO 2 . Endogenously expressed MUC5AC was knocked down using a MUC5AC small hairpin RNA construct (pSUPER-Retro-shMUC5AC) by a stable transfection method. Using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA), MUC5AC small hairpin RNA and scramble vector were transfected into phoenix cells, a packaging cell line that produces high-titer retrovirus in culture.
The cells were then seeded in 24-well plates at a seeding density of 2 × 10 4 cells per well and grown to 40-70% confluency in serum-free growth medium. Culture supernatant medium from transfected phoenix cells was filtered 48 h post transfection, and the viral supernatant was used to infect the cultures of sub confluent A549 and H1437 cells with the addition of 4 μg/ml polybrene. Clones stably transduced with MUC5AC small hairpin RNA construct were selected, maintained using the antibiotic puromycin (4 μg/ml) in 10% RPMI medium and were further expanded to confluent levels to obtain stably transfected cells. 55 
Immunoblot analysis
For immunoblot analysis, the cells were lysed in immunoprecipitation assay buffer (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate) containing protease inhibitors (1 mM phenyl-methyl sulphonyl fluoride, 1 μg/ml aprotinin, 1 μg/ml leupeptin). Cell lysates were centrifuged at 10 000 rpm for 30 min to remove debris, and proteins were quantified using the Bio-Rad DC Protein Assay kit (Bio-Rad Laboratories, Hercules, CA, USA). Total protein (20 μg per well) was fractionated by 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis. For MUC5AC; 2% sodium dodecyl sulfate-agarose gel was used for separation owing to its high molecular weight. Immunoprecipitation analysis MUC5AC (45M1, Abcam Cat # 3649) and integrin β4 (Abcam Cat #133682) antibodies were incubated overnight with A549 cell lysates (500 μg) in a 750 μl total volume. Protein A+G-Sepharose beads (Sigma-Aldrich Corp., St Louis, MO, USA) were added to the lysate-antibody mix and incubated on a rotating platform for 4 h at 4°C and then washed four times with immunoprecipitation assay buffer. The immunoprecipitates and input were electrophoretically resolved on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (8%). Resolved proteins were transferred onto the polyvinyldifluoride membrane. The membranes were blocked in 5% nonfat dry milk in PBS for at least 1 h and then incubated with primary antibodies (anti-integrins (α5, β1, β3, β4 and β5)). The immunoblots were washed five times (5 × 10 min) with PBST, incubated for 1 h with respective secondary antibodies, washed five times (5 × 10 min) with PBST, reacted with enhanced chemiluminescence ECL reagent (GE Healthcare BioSciences) and exposed to X-ray film to detect the signal.
Confocal immunofluorescence microscopy MUC5AC knockdown A549 and H1437 and scramble cells (0.4 × 10 6 cells per well) were grown on sterilized cover slips for 30 h. Cells were washed with Hanks buffer containing 0.1 M 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (2 × 5 min) and fixed in ice-cold methanol at − 20 o C for two min. Similarly, co-immunofluorescence analysis were performed with paraffin embedded mouse lung cancer tissues as described previously. 55 The cells were then blocked with 10% goat serum (Jackson Immunoresearch Labs, Inc., West Grove, PA, USA) for at least 30 min. After blocking, a quick wash was performed using PBS and cells were incubated with antibodies for MUC5AC (mouse 1:1000) and integrin β4 (rabbit, 1:750) for 60 min at room temperature. Then cells were washed (4 × 5 min) with PBS and incubated with fluorescein isothiocyanateconjugated anti-mouse and rhodamine conjugated anti-rabbit secondary MUC5AC in lung cancer I Lakshmanan et al antibodies (Jackson Immunoresearch Labs Inc.) for 30 min at room temperature in the dark. Cells were washed again (5 × 5 min) and mounted on glass slides in anti-fade Vectashield mounting medium (Vector Laboratories, Burlingame, CA, USA). 4',6-diamidino-2-phenylindole was used for nuclear staining. Laser confocal microscopy was performed using an LSM 510 microscope (Carl Zeiss GmbH, Germany).
Quantitative real-time PCR Total RNA was isolated and the cDNA was synthesized by reverse transcription. The primers were designed using Primer 3 software tool and following are the primers used for the study. MUC5AC: Real-time PCR was performed on Roche 480 Real-Time PCR System (Indianapolis, IN, USA). They were performed in triplicates and the template controls were run for each assay under the same conditions. PCR was then performed in 10 μl reaction volume containing 5 μl of SBYR green Master Mix, 3.2 μl of autoclaved nuclease-free water, 1 μl of diluted RT product (1:10) and 0.4 ml each of forward and reverse primers (5 pmol). The cycling conditions comprized of 95°C for 10 min, followed by 40 cycles of 95°C for 15 sec and 58°C for 1 min. Gene expression levels were normalized to the level of β-actin expression.
Cell motility assay
Motility assay was performed by using a chamber containing monolayercoated polyethylene teraphthalate membrane (six-well insert, pore size of 8 μm; Becton Dickinson, Franklin Lakes, NJ, USA). Both scramble and MUC5AC knockdown cells of A549 (2 × 10 6 cells per well) and H1437 (1.5 × 10 6 cells per well) were seeded in six-well plates. After 24 h incubation period, the migrated cells that had reached the lower chamber were stained with a Diff-Quick stain set and counted in different fields. The average number of migrated cells per representative field was calculated. Similarly, for FAK inhibitor treatment studies, cells were seeded along with FAK inhibitor (FAK inhibitor 14, Cayman chemical, CAS4506-66-5), which direct inhibitor and specific for FAK (Y397) 36 and incubated for 24 h and migrated cells were calculated.
Wound-healing assay
For wound-healing assays, 4 × 10 6 of A549 Scr and shMUC5AC cells were seeded in 6-well plates with 10% RPMI 1640 media. After 24 h, cells were treated with 20 μM of FAK inhibitor. A scratch was made on the bottom of each well using a P200 pipette tip. Photographs of the scratch were taken at 0 h and 24 h. The pictures were then analyzed to quantify the change in size of the scratches as the cells migrated into the space in response to FAK inhibitor.
Phosphorylation-specific FAK inhibition
For FAK inhibition, A549 Scr and shMUC5AC cells were seeded in 100mm petri dish with RPMI media. After seeding, cells were treated with phosphorylation-specific FAK inhibitor (20 μM) and for control 0.01% DMSO was used. After treating with the FAK inhibitor, cell viability was calculated as described previously. 56 MTT assay and cisplatin treatment in lung cancer cells Cell viability was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay as described previously. 56 In brief, Scr-A549 and shMUC5AC cells were seeded into a 96-well plate at a density of 8 × 10 3 cells per well in RPMI medium with 10% FBS. After 24 h, the culture media was aspirated and supplemented with fresh media containing different concentrations of cisplatin (20 μM, 25 μM, 30 μM, 35 μM, 40 μM and 45 μM). After 48 h, 10 μl of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (5 mg/ml in PBS) solution were added to each well (including control cells). Then cells were further incubated for 3 h and then the absorbance was read at 560 nm with a reference wavelength of 670 nm using microplate reader. Based on IC 50, we chose 20 μM concentration of cisplatin for further experimental validation of FAK inhibition.
Data analysis
Statistical significance was evaluated with the student t-test using sigmaPlot 11.0 software. P-values o0.05 were considered to be significant. Densitometry analyses were performed using ImageJ software. All experiments were performed in triplicates.
